Citation Impact
Citing Papers
Sex-specific plasma lipid profiles of ME/CFS patients and their association with pain, fatigue, and cognitive symptoms
2021
Plasma β-amyloid in Alzheimer’s disease and vascular disease
2016 StandoutNobel
Long COVID: major findings, mechanisms and recommendations
2023 Standout
Engineering precision nanoparticles for drug delivery
2020 Standout
Bile acid–microbiota crosstalk in gastrointestinal inflammation and carcinogenesis
2017 Standout
Myeloid-derived suppressor cells coming of age
2018 Standout
Reversal of multidrug resistance by the inhibition of ATP-binding cassette pumps employing “Generally Recognized As Safe” (GRAS) nanopharmaceuticals: A review
2013
Neurofilament light chain as a biomarker in neurological disorders
2019 Standout
Protein Nanocapsules Containing Doxorubicin as a pH‐Responsive Delivery System
2011
Evolutionary Conservation of Vertebrate Blood–Brain Barrier Chemoprotective Mechanisms inDrosophila
2009
The glymphatic pathway in neurological disorders
2018 Standout
Nuclear Factor-κB Regulates βAPP and β- and γ-Secretases Differently at Physiological and Supraphysiological Aβ Concentrations
2012
Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging
2013 Standout
Development and evaluation of brain targeted intranasal alginate nanoparticles for treatment of depression
2013
Structure and function of the blood–brain barrier
2009 Standout
Nanoscale drug delivery systems and the blood–brain barrier
2014
Principles of nanoparticle design for overcoming biological barriers to drug delivery
2015 Standout
The Neurovascular Unit Coming of Age: A Journey through Neurovascular Coupling in Health and Disease
2017 Standout
VEGF ligands and receptors: implications in neurodevelopment and neurodegeneration
2013
Molecular targets of celastrol derived from Thunder of God Vine: Potential role in the treatment of inflammatory disorders and cancer
2010
PLGA-based nanoparticles: An overview of biomedical applications
2012 Standout
Organoid Models and Applications in Biomedical Research
2015 Standout
Chronic Neurodegeneration After Traumatic Brain Injury: Alzheimer Disease, Chronic Traumatic Encephalopathy, or Persistent Neuroinflammation?
2014
Stimuli-responsive nanocarriers for drug delivery
2013 Standout
Immunosuppressive Myeloid Cells’ Blockade in the Glioma Microenvironment Enhances the Efficacy of Immune-Stimulatory Gene Therapy
2017
Activity of antibacterial, antiviral, anti-inflammatory in compounds andrographolide salt
2014
Neurovascular Alterations in Alzheimer’s Disease: Transporter Expression Profiles and CNS Drug Access
2017
Nano based drug delivery systems: recent developments and future prospects
2018 Standout
NRF2 and NF-қB interplay in cerebrovascular and neurodegenerative disorders: Molecular mechanisms and possible therapeutic approaches
2018 Standout
Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders
2018 Standout
The Role of Canalicular ABC Transporters in Cholestasis
2014
Immune attack: the role of inflammation in Alzheimer disease
2015 Standout
Chlorogenic acid (CGA): A pharmacological review and call for further research
2017 Standout
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
2019 Standout
Compound profiling for ABCC2 (MRP2) using a fluorescent microplate assay system
2007
The use of nanoparticle-mediated targeted gene silencing and drug delivery to overcome tumor drug resistance
2009
The effect of white matter hyperintensities on cognition is mediated by cortical atrophy
2017
Deciphering the mechanism underlying late-onset Alzheimer disease
2012
Overcoming multidrug resistance of cancer cells by direct intranuclear drug delivery using TAT-conjugated mesoporous silica nanoparticles
2013
Exploring the cellular accumulation of metal complexes
2009
PROTAC targeted protein degraders: the past is prologue
2022 Standout
A natural flavonoid glucoside icariin inhibits Th1 and Th17 cell differentiation and ameliorates experimental autoimmune encephalomyelitis
2014
The Physiological Roles of Amyloid-β Peptide Hint at New Ways to Treat Alzheimer's Disease
2018
Clinical trials of new drugs for Alzheimer disease
2020
Effect of Duloxetine on Pain, Function, and Quality of Life Among Patients With Chemotherapy-Induced Painful Peripheral Neuropathy
2013 Standout
NOX2 drives M1-like microglial/macrophage activation and neurodegeneration following experimental traumatic brain injury
2016
The Neurovascular Link in Health and Disease: Molecular Mechanisms and Therapeutic Implications
2011
Small vessel disease: mechanisms and clinical implications
2019 Standout
Bypassing Multidrug Resistance in Cancer Cells with Biodegradable Polymer Capsules
2010
Up‐regulation of P‐glycoprotein by HIV protease inhibitors in a human brain microvessel endothelial cell line
2008
Flavonoids: an overview
2016 Standout
Plant-derived immunomodulators: an insight on their preclinical evaluation and clinical trials
2015 Standout
Vascular endothelial growth factor: a neurovascular target in neurological diseases
2016
Macrophage M1/M2 polarization
2020 Standout
An update on in vitro test methods in human hepatic drug biotransformation research: pros and cons
2003
Engineering of monosized lipid-coated mesoporous silica nanoparticles for CRISPR delivery
2020 StandoutNobel
The Pathobiology of Vascular Dementia
2013 Standout
Beyond immunotherapy: new approaches for disease modifying treatments for early Alzheimer’s disease
2016
The status of platinum anticancer drugs in the clinic and in clinical trials
2010 Standout
Angiopoietin/Tie2 Axis Regulates the Age-at-Injury Cerebrovascular Response to Traumatic Brain Injury
2018
Brain injury, neuroinflammation and Alzheimer's disease
2013
The overlap between neurodegenerative and vascular factors in the pathogenesis of dementia
2010
Clinically Significant Drug Interactions with Newer Antidepressants
2011
Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?
2020 Standout
Multicomponent reactions for the synthesis of pyrroles
2010 Standout
Oral Druggable Space beyond the Rule of 5: Insights from Drugs and Clinical Candidates
2014
Neuroinflammation: the devil is in the details
2016 Standout
Comprehensive Review on Alzheimer’s Disease: Causes and Treatment
2020 Standout
Lipids and Alzheimer’s Disease
2020
Alzheimer's disease
2017 Standout
Multiplexed Immunoassay Panel Identifies Novel CSF Biomarkers for Alzheimer's Disease Diagnosis and Prognosis
2011
Chemistry of Mesoporous Organosilica in Nanotechnology: Molecularly Organic–Inorganic Hybridization into Frameworks
2016
Hypertension
2013
Association of plasma and cortical amyloid beta is modulated by APOE ε4 status
2013
P-Glycoprotein Recognition of Substrates and Circumvention through Rational Drug Design
2005
Brain microvasculature and hypoxia-related proteins in Alzheimer's disease.
2011
Inorganic Nanoparticle-Based Drug Codelivery Nanosystems To Overcome the Multidrug Resistance of Cancer Cells
2013
Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019
2020 Standout
Blood–Brain Barrier Dysfunction as a Cause and Consequence of Alzheimer's Disease
2013
Gene Transfer of Human Apoe Isoforms Results in Differential Modulation of Amyloid Deposition and Neurotoxicity in Mouse Brain
2013
Overview of pharmacological activities ofAndrographis paniculataand its major compound andrographolide
2018 Standout
Inflammation as a central mechanism in Alzheimer's disease
2018 Standout
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Response of the cerebral vasculature following traumatic brain injury
2017
Differing associations between Aβ accumulation, hypoperfusion, blood–brain barrier dysfunction and loss of PDGFRB pericyte marker in the precuneus and parietal white matter in Alzheimer's disease
2017
The development of anticancer ruthenium(ii ) complexes: from single molecule compounds to nanomaterials
2017 Standout
The Chemistry of Reactive Oxygen Species (ROS) Revisited: Outlining Their Role in Biological Macromolecules (DNA, Lipids and Proteins) and Induced Pathologies
2021 Standout
F‐domain valency determines outcome of signaling through the angiopoietin pathway
2021 StandoutNobel
Inositol Polyphosphate Multikinase Inhibits Angiogenesis via Inositol Pentakisphosphate-Induced HIF-1α Degradation
2017 StandoutNobel
Total Phenolic Content, Flavonoid Content and Antioxidant Potential of Wild Vegetables from Western Nepal
2019 Standout
Neurofilament light and tau as blood biomarkers for sports-related concussion
2018
Penetration of Drugs through the Blood-Cerebrospinal Fluid/Blood-Brain Barrier for Treatment of Central Nervous System Infections
2010 Standout
Heat Shock Protein 90 in Alzheimer’s Disease
2014
ETCM: an encyclopaedia of traditional Chinese medicine
2018 Standout
Flavonoids as Potential Anti-Inflammatory Molecules: A Review
2022 Standout
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
In Vivo Validation of a Small Molecule Inhibitor of Tau Self-Association in htau Mice
2019
Natural Products as Sources of New Drugs from 1981 to 2014
2016 Standout
Flavonoids in Cancer and Apoptosis
2018 Standout
MRP (ABCC) Transporters-Mediated Efflux of Anti-HIV Drugs, Saquinavir and Zidovudine, from Human Endothelial Cells
2008
Human Apolipoprotein E ε4 Expression Impairs Cerebral Vascularization and Blood—Brain Barrier Function in Mice
2014
IKK2/NF‐κB signaling protects neurons after traumatic brain injury
2017
Important Flavonoids and Their Role as a Therapeutic Agent
2020 Standout
Works of Corbin Bachmeier being referenced
COMPARISON OF DRUG EFFLUX TRANSPORT KINETICS IN VARIOUS BLOOD-BRAIN BARRIER MODELS
2006
Reduction of β-amyloid pathology by celastrol in a transgenic mouse model of Alzheimer's disease
2010
Stimulation of the Retinoid X Receptor Facilitates Beta-Amyloid Clearance Across the Blood–Brain Barrier
2012
Anatabine lowers Alzheimer's Aβ production in vitro and in vivo
2011
Induction of drug efflux protein expression by venlafaxine but not desvenlafaxine
2011
Flavonoids lower Alzheimer's Aß production via an NFkB dependent mechanism
2011
Chronic cerebrovascular abnormalities in a mouse model of repetitive mild traumatic brain injury
2016
Quantitative Assessment of HIV-1 Protease Inhibitor Interactions with Drug Efflux Transporters in the Blood–Brain Barrier
2005
A Multifaceted Role for apoE in the Clearance of Beta-Amyloid across the Blood-Brain Barrier
2012
Selective Antihypertensive Dihydropyridines Lower Aβ Accumulation by Targeting both the Production and the Clearance of Aβ across the Blood-Brain Barrier
2010
Drug Efflux Transport Properties of 2′,7′-Bis(2-carboxyethyl)-5(6)-carboxyfluorescein Acetoxymethyl Ester (BCECF-AM) and Its Fluorescent Free Acid, BCECF
2004
In vitro and in vivo models for assessing drug efflux transporter activity
2003
Chronic Repetitive Mild Traumatic Brain Injury Results in Reduced Cerebral Blood Flow, Axonal Injury, Gliosis, and Increased T-Tau and Tau Oligomers
2016
Repetitive Mild Traumatic Brain Injury Augments Tau Pathology and Glial Activation in Aged hTau Mice
2013
Anti-inflammatory activity of anatabine via inhibition of STAT3 phosphorylation
2012
Examination of blood–brain barrier (BBB) integrity in a mouse brain tumor model
2012
Amelioration of Experimental Autoimmune Encephalomyelitis by Anatabine
2013
Impaired Orthotopic Glioma Growth and Vascularization in Transgenic Mouse Models of Alzheimer's Disease
2010
Alzheimer’s β‐amyloid peptide blocks vascular endothelial growth factor mediated signaling via direct interaction with VEGFR‐2
2009
Repetitive Mild Traumatic Brain Injury in a Mouse Model Produces Learning and Memory Deficits Accompanied by Histological Changes
2012
Chronic White Matter Degeneration, but No Tau Pathology at One-Year Post-Repetitive Mild Traumatic Brain Injury in a Tau Transgenic Model
2018
A Fluorometric Screening Assay for Drug Efflux Transporter Activity in the Blood-Brain Barrier
2005
Chronic neuropathological and neurobehavioral changes in a repetitive mild traumatic brain injury model
2013
APOE ε4 specific imbalance of arachidonic acid and docosahexaenoic acid in serum phospholipids identifies individuals with preclinical Mild Cognitive Impairment/Alzheimer’s Disease
2017
Surfactant–Polymer Nanoparticles Overcome P-Glycoprotein-Mediated Drug Efflux
2007